title: Report of successful use of ustekinumab in Crohn's disease refractory to three anti-TNF therapies.
authors.affiliation: Centre for Colorectal Disease, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland, heetunz@gmail.com.
authors.forename: Z S
authors.initials: ZS
authors.lastname: Heetun
authors.forename: D
authors.initials: D
authors.lastname: Keegan
authors.forename: D
authors.initials: D
authors.lastname: O'Donoghue
authors.forename: G A
authors.initials: GA
authors.lastname: Doherty
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D001835:Body Weight; D003424:Crohn Disease / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D056687:Off-Label Use; D012074:Remission Induction; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069549:Ustekinumab